32results about How to "Large solubility" patented technology

A dermatological composition comprising a salt of a cation and an anion. The cation is derived from a monomeric or polymeric molecule that will generate an amidine moieity, a guanidine moieity or a biguanide moieity. The anion is derived from a monomeric or polymeric molecule that will generate a carboxylic acid moieity. The composition may be prepared by a metathesis or acid-base reaction.

A corrosion and erosion resistant alloy comprising as mandatory elements besides iron, in % by weight, about 31 to about 48 chromium, about 0.01 to about 0.7 nitrogen, about 0.5 to about 30 manganese and about 0.3 to about 2.5 carbon. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.

Novel carbon-plus-nitrogen corrosion-resistant ferrous and austenitic alloys, apparatus incorporating an inventive alloy, and methods of making and using the apparatus are described. The corrosion-resistant ferrous and austenitic alloys comprise no greater than about 4 wt. % nickel, are characterized by a strength greater than about 700 MPa (100 ksi), and, when being essentially free of molybdenum (<0.3 wt. %), have minimum Pitting Resistance Equivalence (PRE) numbers of 20 and minimum Measure of Alloying for Corrosion Resistance numbers (MARC) of 30 because of the use of both carbon and nitrogen. The ferrous and austenitic alloys are particularly formulated for use in oilfield operations, especially sour oil and gas wells and reservoirs. This abstract allows a searcher or other reader to quickly ascertain the subject matter of the disclosure. It will not be used to interpret or limit the scope or meaning of the claims.

Disclosed are certain polymeric compounds and their use as organic semiconductors in organic and hybrid optical, optoelectronic, and/or electronic devices such as photovoltaic cells, light emitting diodes, light emitting transistors, field effect transistors, and photodetectors. The disclosed compounds can provide improved device performance, for example, as measured by power conversion efficiency, fill factor, open circuit voltage, field-effect mobility, on/off current ratios, and/or air stability when used in photovoltaic cells or transistors. The disclosed compounds can have good solubility in common solvents enabling device fabrication via solution processes.

A method for preparing nanocrystalline ceramic thin films, particularly at low firing temperatures <1000° C. The method for preparing ceramic thin films comprises preparing a seed gel of metal oxide, dissolving a source compound for cations of the oxide's metal constituents in the solution, then adding a polymerizable organic solvent to the solution and heating to form a polymeric precursor having uniformly dispersed gel seeds within a solid gel structure whereby any voids within the structure are filled with metal cation-containing polymeric precursor. The polymeric precursor is free of precipitates. A surface of a substrate is then coated with at least one layer of the gel-seeded polymeric precursor to form a uniform film of gel-seeded polymeric precursor wherein the film has a thickness of 100 nm to 200 nm per layer. The film is then sintered to convert the film to a nanocrystalline ceramic thin film having a thickness of 100 nm to 1 mum and being substantially free of defects.

A liquid crystal composition comprising at least one liquid crystal compound and at least one anthraquinone compound represented by formula (1) below: Formula (1) (wherein R<2 >to R<8 >each independently represents a hydrogen or substituent; Het is a sulfur or oxygen; B<1 >and B<2 >each independently represents an optionally substituted arylene, heteroarylene, cycloalkan-diyl or cycloalken-diyl; Q<1 >is a bivalent linking group; C<1 >is an optionally substituted alkyl, cycloalkyl, alkoxy, alkokycarbonyl or acyloxy; p, q and r each represents a number from 0 to 5 and n is a number from 1 to 3 satisfying 3<=(p+r)xn<=10; when plural {(B<1>)p-(Q<1>)q-(B<2>)r} are present, these may be the same or different) was disclosed.

A positive planographic printing plate precursor comprising a recording layer containing a water-insoluble and alkali-soluble resin, an infrared absorbent and an organic quaternary ammonium salt. A positive planographic printing plate precursor comprising at least two recording layers containing the resin and the infrared absorbent with a coating amount of an upper positive recording layer being in the range of 0.05 to 0.45 g/m².

Whey protein materials such as whey from cheese making processes, whey protein concentrates, and whey protein isolates, are deflavored by adjusting the pH of an aqueous composition of such whey protein materials to about 8.0 to about 12 using membrane electrodialysis to solubilize the whey proteins and to release the flavoring compounds and thereafter passing the pH-adjusted composition to an ultrafiltration membrane having a molecular weight cutoff up to about 50,000 Daltons under conditions at which the flavoring compounds pass through the membrane, leaving the retained whey protein material with improved flavor. the membrane, leaving the retained whey protein material with improved flavor.

Provided in the present invention is a cabazitaxel fat emulsion injection, wherein the cabazitaxel fat emulsion injection contains cabazitaxel, a medium chain triglyceride for injection, and lecithin. Also provided in the present invention are the method for preparing the cabazitaxel fat emulsion injection and the use thereof in preparing a drug for treating prostate cancer.

The present invention provides an ethylene-vinyl alcohol based copolymer (EVOH) having fundamentally improved thermal stability. The EVOH is characterized in that the proportion of ethylene units (III) is from 20 to 60 mole % with respect to the total (III+IV+V) of ethylene units (III), vinyl alcohol units (IV), and vinyl ester units (V), and the proportion of the total (I+II) of carboxylic acids units (I) and lactone ring units (II) in copolymer terminals with respect to the total (III+IV+V) is 0.12 mole % or less. The EVOH can be obtained by, for example, contacting a reducing agent with an ethylene-vinyl ester based copolymer before saponification and/or EVOH after saponification.

A gallium phthalocyanine compound represented by the following chemical structure I,

This invention relates generally to C—H activated ruthenium olefin metathesis catalyst compounds which are stereogenic at the ruthenium center, to their preparation, and the use of such catalysts in the metathesis of olefins and olefin compounds. In particular, the invention relates to the use of C—H activated ruthenium olefin metathesis catalyst compounds in Z-selective olefin metathesis reactions, enantio-selective olefin metathesis reactions, and enantio-Z-selective olefin metathesis reactions. The invention has utility in the fields of catalysis, organic synthesis, polymer chemistry, and industrial and fine chemicals chemistry.

The present invention relates to a new amorphous form of rifaximin and to methods for the preparation thereof by means of high energy milling or Spray drying. The present invention further relates to a new amorphous form for use as medicament and to the pharmaceutical compositions composing it.

Disclosed is a photosensitive resin composition comprising an alkali-soluble resin, wherein the dissolution rate of the alkali-soluble resin in an aqueous sodium carbonate solution is not less than 0.04 μm/sec. When a photosensitive layer having a thickness of 30 μm is formed by applying the photosensitive resin composition onto a base and removing the solvent by heating, and thus-obtained photosensitive layer is irradiated with an active ray of 1000 mJ/cm² or less, the dissolution rate of the portion irradiated with the active ray in the photosensitive layer made of the photosensitive resin composition is not less than 0.22 μm/sec and the film residual rate of the portion not irradiated with the active ray is not less than 90%.

The invention makes public a preparing method for xanthophyll crystals with higher content of zeaxanthin from plant oleoresin. The current methods generally are to get quite pure crystal forms of xanthophyll or zeaxanthin, and they refer to several separation steps. The invention mixes the xanthophyll diester-containing plant oleoresins and food grade alcohol solvents to form even solution, and then soap-dissolve the solution under an alkaline environment; then replenish organic solvents and emulsifiers into the reaction solution and drop some alkali solution into the solution to make partial xanthophyll crystals be transformed to be zeaxanthin through epimerization reaction; after the reaction is finished, add the mixed solvents of alcohol solvent and water to separate out the crystals; use the method of centrifugation or filtration to get the crystals; wash the crystals several times with the mixed solution of deionized water and alcohols to remove the impurities among the crystals; recrystallize the gained crystals with absolute ethyl alcohol, and then dry the crystals to get the products. The invention can gain mixture crystals that contain xanthophyll and zeaxanthin at one time in quite high collection rate, and it is convenient for the followed product application.